Has fallen far enough . In today . Over all there is plenty to like about LBT.
Adelaide, Australia, 13 March 2024: Australian medical technology company LBT Innovations Limited (ASX: LBT) (LBT orthe Company), a leader in microbiology automation using artificial intelligence, is pleased to announce the successfulcompletion of primary validation for the APAS® PharmaQC product. The completion of the milestone represents the final stepin the product development and technology commercialisation.
IMO
LBT Price at posting:
2.0¢ Sentiment: Buy Disclosure: Held
